Superoxide anion production during reperfusion is reduced by an antineutrophil antibody after prolonged cerebral ischemia

Free Radical Biology and Medicine

Volumn 26, Issue 3-4, 1999, Pages 355-361

  Fabian, Roderic H ^a   Kent, Thomas A ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

AntiCD18 antibody; Focal cerebral ischemia; Free radical; Neutrophil; Reperfusion injury; Superoxide anion

Indexed keywords

GRANULOCYTE ANTIBODY; SUPEROXIDE;

ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; FEMALE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ACTIVATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ANTIBODIES; ANTIGENS, CD18; BRAIN ISCHEMIA; ELECTROCHEMISTRY; FEMALE; FREE RADICALS; MALE; NEUTROPHILS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SUPEROXIDES;

ANIMALIA;

EID: 0032930753     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00215-9     Document Type: Article

References (27)

1. Siesjo B.K., Siesjo P. Mechanisms of secondary brain injury. Eur. J. Anaesth. 13:1996;247-268.
2. Chopp M., Zhang R.L., Chen H., Li Y., Jiang N., Rusche J.R. Postischemic administration of an antiMac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke. 25:1994;869-875.
3. Clark W.M., Madden K.P. Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke. 22:1991;877-883.
4. Connolly E.S. Jr, Winfree C.J., Springer T.A., Naka Y., Liao H., Yan S.D., Stern D.M., Solomon R.A., Gutierrez-Ramos J.C., Pinsky D.J. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97:1996;209-216.
5. Jiang N., Moyle M., Soule H.R., Rote W.E., Chopp M. Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats. Ann. Neurol. 38:1995;935-942.
6. Lindsberg P.J., Siren A.L., Feuerstein G.Z., Hallenbeck J.M. Antagonism of neutrophil adherence in the deteriorating stroke model in rabbits. J. Neurosurg. 82:1995;269-277.
7. Matsuo Y., Kihara T., Ikeda M., Ninomiya M., Onodera H., Kogure K. Role of neutrophils in radical production during ischemia and reperfusion of the rat brain effect of neutrophil depletion on extracellular ascorbyl radical formation . J. Cereb. Blood Flow Metab. 15:1995;941-947.
8. Nelson C.W., Wei E.P., Povlishock J.T., Kontos H.A., Moskowitz M.A. Oxygen radicals in cerebral ischemia. Am. J. Physiol. 263:1992;H1356-H1362.
9. Matsuo Y., Onodera H., Shiga Y., Nakamura M., Ninomiya M., Kihara T., Kogure K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke. 25:1994;1469-1475.
10. Matsuo Y., Onodera H., Shiga Y., Shozuhara H., Ninomiya M., Kihara T., Tamatani T., Miyasaka M., Kogure K. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res. 656:1994;344-352.
11. Takeshima R., Kirsch K.R., Koehler R.C., Gomoll A.W., Traystman R.J. Monoclonal leukocyte antibody does not decrease the injury of transient focal cerebral ischemia in cats. Stroke. 23:1992;247-252.
12. Zhang R.L., Chopp M., Jiang N., Tang W.X., Prostak J., Manning A.M., Anderson D.C. Antiintercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke. 26:1995;1438-1442.
13. Kontos H.A., Wei E.P., Ellis E.F., Jenkins L.W., Povlishock J.T., Rowe G.T., Hess M.L. Appearance of superoxide anion radical in cerebral extracellular space during increased prostaglandin synthesis in cats. Circ. Res. 57:1985;142-151.
14. Fabian R.H., DeWitt D.S., Kent T.A. In vivo detection of superoxide anion production by the brain using a cytochrome c electrode. J. Cereb. Blood Flow Metab. 15:1995;242-247.
15. Zhang R., Chopp M. Administration of antiCD18 antibody extends the therapeutic window for thrombolysis in rats. Stroke. 29:1998;282.
16. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
17. Quast M.J., Huang N.C., Hillman G.R., Kent T.A. The evolution of acute stroke recorded by multimodal magnetic resonance imaging. Magn. Reson. Imaging. 11:1993;465-471.
18. Tamatani T., Miyasaka M. Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int. Immunol. 2:1990;165-171.
19. McNeil C.J., Smith K.A., Bellavite P., Bannister J.V. Application of the electrochemistry of cytochrome c to the measurement of superoxide radical production. Free Radic. Res. Comm. 7:1989;89-96.
20. McNeil C.J., Greenough K.R., Weeks P.A., Self C.H. Electrochemical sensors for direct reagentless mesurement of superoxide production by human neutrophils. Free Radic. Res. Comm. 17:1992;399-406.
21. Clark R.K., Lee E.V., White R.F., Jonak Z.L., Feuerstein G.Z., Barone F.C. Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res. Bull. 35:1994;387-392.
22. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333:1995;1581-1587.
23. Barone F.C., Schmidt D.B., Hillegass L.M., Price W.J., White R.F., Feuerstein G.Z., Clark R.K., Lee E.V., Griswold D.E., Sarau H.M. Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia. Stroke. 23:1992;1337-1347.
24. Dirnagl U., Niwa K., Sixt G., Villringer A. Cortical hypoperfusion after global forebrain ischemia in rats is not caused by microvascular leukocyte plugging. Stroke. 25:1994;1028-1038.
25. Aronowski J., Strong R., Grotta J.C. Combined neuroprotection and reperfusion therapy for stroke. Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia. Stroke. 27:1996;1571-1576.
26. Bowes M.P., Rothlein R., Fagan S.C., Zivin J.A. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology. 45:1995;815-819.
27. Stanimirovic D.B., Micic D.V., Markovic M., Spatz M., Mrsulja B.B. 'Therapeutic window' for multiple drug treatment of experimental cerebral ischemia in gerbils. Neurochem. Res. 19:1994;189-194.